Mumbai, Maharashtra, India, December 2025 — Swapnil Shah has been promoted as Divisional Head (GM – Sales & Marketing) at Zydus Group, marking a significant leadership elevation within one of India’s most respected global life-sciences organizations. In his expanded role, he now leads the flagship ZIVA Division, with full P&L ownership and strategic responsibility for market expansion, brand growth, digital acceleration and commercial excellence.
With nearly 13 years at Zydus Group, Swapnil has consistently progressed through leadership ranks on the strength of sustained business performance, successful brand transformations and high-impact market strategies. His elevation reflects Zydus’ confidence in his ability to drive the next phase of dermatology and specialty portfolio expansion.
In his current leadership phase at Zydus Group, Swapnil spearheads the ZIVA Division, directing end-to-end commercial strategy, portfolio innovation, digital transformation and sales productivity optimization. He has played a pivotal role in repositioning the dermatology business into focused verticals — LIVA, ZIVA and EVA — strengthening therapeutic specialization and accelerating sustainable growth. His initiatives have expanded digital and D2C penetration through platforms such as CUTICOLOR, strengthened KOL and HCP engagement, and enhanced ROI through advanced sales productivity models.
Prior to this elevation, he served as Deputy General Manager – Marketing at Zydus Group, where he drove large-scale brand portfolio restructuring, digital engagement strategy deployment and leadership capability development across multiple therapeutic verticals, significantly strengthening Zydus’ dermatology leadership in India.
Earlier, Swapnil held senior marketing leadership roles at Wockhardt Ltd., where he led the insulin and SMBG portfolio, driving major therapy-area expansions and innovative patient engagement models.
He began his managerial leadership journey with Abbott, managing chronic care portfolios including statins and beta blockers, before earlier assignments at USV Private Limited and GlaxoSmithKline, where he built a strong foundation in pharmaceutical brand strategy, product launches and physician engagement programs.
About Zydus Group
The Zydus Group is a global life-sciences organization committed to empowering people with healthier and more fulfilled lives. With over 27,000 employees worldwide, Zydus discovers, develops, manufactures and markets a wide range of healthcare therapies across multiple geographies. Driven by innovation and scientific excellence, Zydus continues to transform healthcare through path-breaking discoveries and high-quality therapeutic solutions.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
